BULL, FUTU rise premarket after earnings-linked news flow
BULL and FUTU are up 10% premarket on earnings-related news, while DE gains 4% on earnings and RARE rises 6% on U.S. FDA approval of GENGLYCOS gene therapy.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.